<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Xu, Risheng</style></author><author><style face="normal" font="default" size="100%">Abate, Nicola</style></author><author><style face="normal" font="default" size="100%">Ram, Nalini</style></author><author><style face="normal" font="default" size="100%">Little, Kristina</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Most elderly patients with subclinical hypothyroidism do not need to be treated</style></title><secondary-title><style face="normal" font="default" size="100%">Cleveland Clinic Journal of Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2025-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">221-231</style></pages><doi><style  face="normal" font="default" size="100%">10.3949/ccjm.92a.24098</style></doi><volume><style face="normal" font="default" size="100%">92</style></volume><issue><style face="normal" font="default" size="100%">4</style></issue><abstract><style  face="normal" font="default" size="100%">Whether subclinical hypothyroidism should be treated in elderly patients (≥ 65 years) is controversial. The authors argue for a personalized, wait-and-see approach rather than universal treatment, pointing out that randomized clinical trials have not shown that levothyroxine treatment makes any difference in terms of hard clinical end points, quality of life, or hypothyroid symptom relief in elderly patients with this condition.</style></abstract></record></records></xml>